A phase I study of cediranib (NSC #732208) in combination with cisplatin and pemetrexed in chemonaive patients with malignant pleural mesothelioma (SWOG S0905).
Anne S. Tsao
No relevant relationships to disclose
James Moon
No relevant relationships to disclose
Ignacio Ivan Wistuba
No relevant relationships to disclose
Nicholas J. Vogelzang
No relevant relationships to disclose
Gregory Peter Kalemkerian
No relevant relationships to disclose
Mary Weber Redman
No relevant relationships to disclose
David R. Gandara
No relevant relationships to disclose